Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


European Journal of Endocrinology, Vol 133, Issue 4, 445-450
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snel, Y.
Right arrow Articles by Koppeschaar, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snel, Y.
Right arrow Articles by Koppeschaar, H.

Clinical Studies

Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy

YE Snel, ME Doerga, RJ Brummer, PM Zelissen, ML Zonderland, and HP Koppeschaar

Department of Endocrinology, University Hospital Utrecht, The Netherlands.

The resting metabolic rate (RMR), and body composition were assessed in 30 growth hormone-deficient (GHD) adults before and after 3 and 6 months of replacement therapy with recombinant human growth hormone (rhGH). In addition, insulin-like growth factor I (IGF-I), IGF binding proteins (IGFBPs) and plasma insulin were measured at baseline and at 6 months in relation to RMR. During 6 months of rhGH replacement therapy, body fat decreased from 18.2 +/- 1.5 (mean +/- SEM) to 14.3 +/- 1.6 kg (p < 0.0001), whereas fat-free mass (FFM) increased from 53.5 +/- 3.3 to 56.3 +/- 3.6 kg (p < 0.0001), RMR increased from 1246 +/- 92 to 1539 +/- 102 kcal/24 h (p < 0.0001) and RMR per kilogram of FFM increased from 23.2 +/- 0.6 to 27.4 +/- 0.5 (p < 0.0001). When RMR data were adjusted for the differences in FFM, it appeared that apart from the increase in FFM, other factors may play a role in the increase in RMR. During rhGH replacement therapy, IGF-I (p < 0.0001) and IGFBP-3 (p = 0.003) levels increased, whereas IGFBP-1 levels decreased significantly (p = 0.004). The FFM explained for about 80% of the variance in RMR. In addition, waist/hip ratio and plasma IGF-I contributed significantly to the explained variance of RMR. This study shows that in GHD adults FFM is the main determinant of RMR and that, next to the increase in FFM, changes in metabolic and hormonal parameters contribute to the increase in RMR during rhGH replacement therapy.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat
The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults
Endocr. Rev., May 1, 2006; 27(3): 287 - 317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Hansen, R. Morthorst, B. Larsson, A. Flyvbjerg, M. H. Rasmussen, H. Orskov, A. Astrup, M. Kjaer, and K. H. W. Lange
Effects of 2 wk of GH administration on 24-h indirect calorimetry in young, healthy, lean men
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1030 - E1038.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. K. Biller, G. Sesmilo, H. B. A. Baum, D. Hayden, D. Schoenfeld, and A. Klibanski
Withdrawal of Long-Term Physiological Growth Hormone (GH) Administration: Differential Effects on Bone Density and Body Composition in Men with Adult-Onset GH Deficiency
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 970 - 976.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. B. Pedersen, K. Kristensen, S. Fisker, J. O. L. Jørgensen, J. S. Christiansen, and B. Richelsen
Regulation of Uncoupling Protein-2 and -3 by Growth Hormone in Skeletal Muscle and Adipose Tissue in Growth Hormone-Deficient Adults
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4073 - 4078.
[Abstract] [Full Text]


Home page
NEJMHome page
M. L. Vance and N. Mauras
Growth Hormone Therapy in Adults and Children
N. Engl. J. Med., October 14, 1999; 341(16): 1206 - 1216.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. V. Carroll, E. R. Christ the members of Growth Hormone Research Soci, B. A. Bengtsson, L. Carlsson, J. S. Christiansen, D. Clemmons, R. Hintz, K. Ho, Z. Laron, P. Sizonenko, et al.
Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 382 - 395.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Fisker, N. Vahl, J. O. L. Jorgensen, J. S. Christiansen, and H. Orskov
Abdominal Fat Determines Growth Hormone-Binding Protein Levels in Healthy Nonobese Adults
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 123 - 128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.